Condition
Cardiorenal Syndrome
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 32 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
32 shownFeasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVADNCT03836482 · 2025-10-02
RECRUITINGExercise Rehabilitation for Cardiorenal Syndrome in HFrEF PatientsNCT07167368 · 2025-09-15
RECRUITINGVenous Ultrasound Guided Organ Decongestion in Patients Hospitalized with Acute Decompensated Heart FailureNCT06714409 · 2024-09-16
RECRUITINGDiuretics Alone vs. Aortix Endovascular Device for Acute Heart FailureNCT05677100 · 2023-08-23
RECRUITINGCardiorenal Syndrome: Characteristics and Prognostic Impact in Advanced Heart FailureNCT07666516 · 2026-09-01
NOT_YET_RECRUITINGMonitoring of the Sympathetic/Vagal Balance Through Multiparametric Analysis of Heart Rate Variability (HRV)NCT07471802 · 2026-05-20
ACTIVE_NOT_RECRUITINGFrench AKI Registry (FAKIR): A Multicenter Study on the In-Hospital Management and Outcomes of Severe Acute Kidney Injury in Nephrology UnitsNCT07123324 · 2025-11-01
NOT_YET_RECRUITINGSCD for CRS in Congestive Heart Failure (CHF) (No Left Ventricular Assist Device)NCT04589065 · 2025-09-01
SUSPENDEDEffects of a Supervised Training Program on Functional Capacity in Patients With HF and Cardiorenal SyndromeNCT06640140 · 2024-10-08
NOT_YET_RECRUITINGFeasibility Study to Support Cardiorenal Function in Acute Decompensated Heart Failure With Diuretic ResistanceNCT06174623 · 2024-08-01
UNKNOWNSodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility StudyNCT06111768 · 2024-05-30
COMPLETEDCardiorenal and Metabolic Effects of Nighttime EatingNCT06588088 · 2022-05-01
COMPLETEDEffect on Kidney Function Recovery Guiding Decongestion With VExUS in Patients With Cardiorenal Syndrome 1NCT05927285 · 2022-03-20
COMPLETEDThe Aortix CRS Pilot StudyNCT04145635 · 2021-02-05
COMPLETEDVolume Optimization Incorporating Negative Pressure Diuresis in Heart Failure (VOID-HF)NCT04227977 · 2020-06-12
COMPLETEDAlfapump Direct Sodium Removal (DSR) Feasibility StudyNCT04116034 · 2019-12-26
COMPLETEDRenal Venous Flow and Cardiac Surgery-associated Acute Kidney InjuryNCT03753607 · 2018-12-20
COMPLETEDAssociation Between Renal and Right Cardiac Functions After Urinary Sodium Depletion Following Cardiac SurgeryNCT03684876 · 2018-06-01
TERMINATEDThe Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide.NCT04393493 · 2017-07-01
COMPLETEDImplementation of Telerehabilitation In Support of HOme-based Physical Exercise for Heart FailureNCT03183323 · 2017-06-08
COMPLETEDPredictive Value of Renal Venous Flow Profiles for Adverse Outcomes in Right Heart FailureNCT03039959 · 2016-11-01
COMPLETEDA Trial of Doxycycline in Renal DiseaseNCT02753426 · 2016-04-01
COMPLETEDDobutamaine Versus Milrinone in Cardiorenal SyndromeNCT02644057 · 2016-03-01
WITHDRAWNCardiorenal Syndrome in End-Stage Kidney DiseaseNCT02238093 · 2014-10-01
UNKNOWNLevosimendan Versus Dobutamine for Renal Function in Heart FailureNCT02133105 · 2014-04-01
COMPLETEDNesiritide and Renal Function After the Total Artificial HeartNCT01836809 · 2013-04-01
TERMINATEDValue of Renal Vascular Doppler Sonography in Management of Decompensated Heart FailureNCT02372292 · 2013-02-01
COMPLETEDBiomonitoring and Cardiorenal Syndrome in Heart Failure(BIONICS-HF) TrialNCT01570153 · 2012-03-01
COMPLETEDLevosimendan Infusion in Critically Ill Patients With Cardiogenic ShockNCT04917497 · 2011-06-30
COMPLETEDAccuracy of Urinary NGAL in Predicting CardioRenal Syndrome in Acute Heart Failure at Emergency - CYNDERELA-HF StudyNCT01364636 · 2011-02-01
TERMINATEDParicalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant PatientsNCT01265615 · 2009-10-01
COMPLETEDUse of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney FailureNCT00348556 · 2005-12-01
TERMINATEDCommon interventions
Aortix SystemDEVICE2DobutamineDRUG2LevosimendanDRUG2NesiritideDRUG2Selective Cytopheretic DeviceDEVICE2alfapump DSR systemDEVICE1CalcitriolDRUG1Cardiorenal syndrome follow-upOTHER1ChlortalidoneDRUG1CholecalciferolDRUG1Control groupOTHER1DapagliflozinDRUG1DietaryOTHER1diuretic usePROCEDURE1DoxycyclineDRUG1Furosemide intravenous solutionDRUG1HOLTER ECG monitoringDIAGNOSTIC_TEST1Home-based Personalized Exercise RehabilitationBEHAVIORAL1intravenous furosemideDRUG1JuxtaFlow SystemDEVICE1MilrinoneDRUG1ModulHeart SupportDEVICE1No interventionDIAGNOSTIC_TEST1No interventionOTHER1ParicalcitolDRUG1
Leading sponsors
Hospital Civil de Guadalajara
2
Procyrion
2
University of Giessen
2
3ive Labs
1
Ankara University
1
Centre Hospitalier Universitaire, Amiens
1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
1
Fundación para la Investigación del Hospital Clínico de Valencia
1
Göteborg University
1
Haiyan Pan
1
Helse Nord-Trøndelag HF
1
Hillel Yaffe Medical Center
1
Horng Chen
1
Hospices Civils de Lyon
1
Koc University Hospital
1
Trial status mix
COMPLETED16
RECRUITING4
TERMINATED4
NOT_YET_RECRUITING3
UNKNOWN2
ACTIVE_NOT_RECRUITING1
SUSPENDED1
WITHDRAWN1
Phase mix
NA15
PHASE24
PHASE12
PHASE42
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.